# Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

Study · id `cardio:ct-nct02022293` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02022293](<https://clinicaltrials.gov/study/NCT02022293>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02022293

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 324 participants.

## Technical summary

Registry record NCT02022293. Randomized; double masking; primary purpose prevention. Start 2017-01 (actual); primary completion 2023-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 324 participants (planned count; ClinicalTrials.gov record NCT02022293, source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)
- Started: 2017-01 (actual) (ClinicalTrials.gov record NCT02022293, source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)
- Primary completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT02022293, source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)
- Completion: 2024-01 (anticipated) (ClinicalTrials.gov record NCT02022293, source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02022293, source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02022293-2017-12-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
- Condition: Nasopharyngeal Carcinoma
- Condition: Radiation Therapy Complication
- Intervention (Drug): Atorvastatin
- Intervention (Other): Placebo
- Lead sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (`cardio:org-sun-yat-sen-memorial-hospital-of-sun-yat-sen-university`)

## Provenance

Content hash: 8357d74ebc14f17a961aaa3c35111d43d925b610f458752bb45440d8243c1ec6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
